{"transactions":[{"id":4628363,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-29T20:42:37.000Z","date":"2026-09-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":7928,"price":0.7592,"value":6018.9376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."}],"balance_after":461808,"source":{"system":"sec-edgar","filing":"0001193125-26-407684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000119312526407684/ownership.xml","form_type":"4"}},{"id":705229,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:29:00.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":0.7198,"value":25193.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":469736,"source":{"system":"sec-edgar","filing":"0001869579-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000007/ownership.xml","form_type":"4"}},{"id":705228,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2026-06-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":7927,"price":0.74,"value":5865.98,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":434736,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":705227,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2026-03-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":9099,"price":0.81,"value":7370.19,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":442663,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":705226,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2026-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":8916,"price":1.13,"value":10075.08,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":451762,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":705225,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2025-12-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":7906,"price":1.4,"value":11068.4,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":460678,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":705224,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2025-09-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":9077,"price":0.48,"value":4356.96,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":468584,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":705223,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2025-06-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":9076,"price":0.55,"value":4991.8,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":477661,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":705222,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-21T22:25:12.000Z","date":"2024-12-27","kind":"sale","planned":false,"acquired":false,"shares":8014,"price":1.41,"value":11299.74,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of the restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":486737,"source":{"system":"sec-edgar","filing":"0001869579-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000006/ownership.xml","form_type":"4"}},{"id":748207,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:14:52.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":3800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from April 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through each such vesting date."}],"balance_after":3800000,"derivative":{"exercise_price":0.875,"expiration_date":"2036-06-02","underlying":"Class A Common Stock","underlying_shares":3800000},"source":{"system":"sec-edgar","filing":"0001869579-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000186957926000003/ownership.xml","form_type":"4"}},{"id":1135559,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T21:58:52.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":1053000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from May 23, 2025."}],"balance_after":1053000,"derivative":{"exercise_price":0.6168,"expiration_date":"2035-05-22","underlying":"Class A Common Stock","underlying_shares":1053000},"source":{"system":"sec-edgar","filing":"0000950170-25-077179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017025077179/ownership.xml","form_type":"4"}},{"id":1337385,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-10T18:12:17.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":10296,"price":1.94,"value":19974.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":494751,"source":{"system":"sec-edgar","filing":"0000950170-24-134828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017024134828/ownership.xml","form_type":"4"}},{"id":1563594,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-23T01:00:10.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1085000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024."}],"balance_after":1085000,"derivative":{"exercise_price":3.6,"expiration_date":"2034-03-20","underlying":"Class A Common Stock","underlying_shares":1085000},"source":{"system":"sec-edgar","filing":"0000950170-24-035573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017024035573/ownership.xml","form_type":"4"}},{"id":1705183,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":31252,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021."}],"balance_after":31252,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":31252},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705182,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31252,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021."}],"balance_after":47699,"derivative":{"exercise_price":9.44,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":31252},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705181,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"271875","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":271875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years."}],"balance_after":271875,"derivative":{"exercise_price":2.84,"expiration_date":"2031-09-08","underlying":"Class A Common Stock","underlying_shares":271875},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705180,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":271875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years."}],"balance_after":453125,"derivative":{"exercise_price":19.56,"expiration_date":"2031-09-08","underlying":"Class A Common Stock","underlying_shares":271875},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705179,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":153650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."}],"balance_after":153650,"derivative":{"exercise_price":2.84,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":153650},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705178,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":153650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":109750,"derivative":{"exercise_price":13.21,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":153650},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705177,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":479667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."}],"balance_after":479667,"derivative":{"exercise_price":2.84,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":479667},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1705176,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:29.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":479667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":95933,"derivative":{"exercise_price":5.44,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":479667},"source":{"system":"sec-edgar","filing":"0000950170-23-071472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023071472/ownership.xml","form_type":"4"}},{"id":1719188,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-07T22:18:12.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.27,"value":22700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":484455,"source":{"system":"sec-edgar","filing":"0000950170-23-068864","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023068864/ownership.xml","form_type":"4"}},{"id":1720244,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-06T13:00:04.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.57,"value":12850.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":474455,"source":{"system":"sec-edgar","filing":"0000950170-23-068442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023068442/ownership.xml","form_type":"4"}},{"id":1725648,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-01T13:00:04.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.05,"value":41000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":469455,"source":{"system":"sec-edgar","filing":"0000950170-23-067149","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023067149/ownership.xml","form_type":"4"}},{"id":1745873,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-09T21:05:10.000Z","date":"2023-11-07","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.01,"value":5025.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":449455,"source":{"system":"sec-edgar","filing":"0000950170-23-062001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023062001/ownership.xml","form_type":"4"}},{"id":1745872,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-09T21:05:10.000Z","date":"2023-11-07","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.98,"value":4950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":446955,"source":{"system":"sec-edgar","filing":"0000950170-23-062001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000095017023062001/ownership.xml","form_type":"4"}},{"id":1935877,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-30T00:59:01.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":575600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows:  1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."}],"balance_after":575600,"derivative":{"exercise_price":5.44,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":575600},"source":{"system":"sec-edgar","filing":"0001415889-23-005592","document":"form4-03302023_120352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000141588923005592/form4-03302023_120352.xml","form_type":"4"}},{"id":1935876,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Class A Common Stock","published_at":"2023-03-30T00:59:01.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":353500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows:  1/16th of the RSUs shall vest quarterly over four years from March 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,343 shares held by VH Moll, L.P.  The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":444445,"source":{"system":"sec-edgar","filing":"0001415889-23-005592","document":"form4-03302023_120352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000141588923005592/form4-03302023_120352.xml","form_type":"4"}},{"id":1939259,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Class A Common Stock","published_at":"2023-03-24T20:05:20.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":7988,"price":5.95,"value":47528.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Imran on March 22, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":90945,"source":{"system":"sec-edgar","filing":"0000899243-23-009585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000089924323009585/doc4.xml","form_type":"4"}},{"id":2319027,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T01:10:09.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":263400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."}],"balance_after":263400,"derivative":{"exercise_price":13.21,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":263400},"source":{"system":"sec-edgar","filing":"0001209191-22-021022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000120919122021022/doc4.xml","form_type":"4"}},{"id":2319026,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-25T01:10:09.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":86600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022."}],"balance_after":98943,"source":{"system":"sec-edgar","filing":"0001209191-22-021022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000120919122021022/doc4.xml","form_type":"4"}},{"id":2410311,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-08T02:52:36.000Z","date":"2022-02-03","kind":"other","acquired":true,"shares":12343,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"VH Moll, L.P., is a limited partner of VH Rani, LP. VH Moll, L.P. therefore received 12,343 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person is a member of the general partner and disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"VH Moll, L.P., is a limited partner of VH Rani, LP. VH Moll, L.P. therefore received 12,343 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person is a member of the general partner and disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":12343,"source":{"system":"sec-edgar","filing":"0001209191-22-007647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000120919122007647/doc4.xml","form_type":"4"}},{"id":2410310,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-08T02:52:36.000Z","date":"2022-02-03","kind":"other","acquired":false,"shares":827467,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Biologix Partners, LP and VH Rani, LP. distributed these shares to its limited partners on a pro rata basis, for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents previously held 378,564 shares of Class A Common Stock of the Issuer (\"Class A Shares\") held by Biologix Partners, LP and 448,903 Class A Shares held by VH Rani, LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents previously held 378,564 shares of Class A Common Stock of the Issuer (\"Class A Shares\") held by Biologix Partners, LP and 448,903 Class A Shares held by VH Rani, LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-007647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000120919122007647/doc4.xml","form_type":"4"}},{"id":2572162,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":29315,"kind":"person","name":"Imran Talat","position":1,"cik":"0001869579","reported_name":"Imran Talat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-14T00:01:34.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":725000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years."}],"balance_after":725000,"derivative":{"exercise_price":19.56,"expiration_date":"2031-09-09","underlying":"Class A Common Stock","underlying_shares":725000},"source":{"system":"sec-edgar","filing":"0001209191-21-055770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869579/000120919121055770/doc4.xml","form_type":"4"}}]}